• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/24 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulfur atoms by sulfur atoms to which a second hetero atom is attached

Patent holdings for IPC class C07D 211/24

Total number of patents in this class: 78

10-year publication summary

4
7
4
6
6
7
2
5
3
2
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Prilenia Neurotherapeutics Ltd.
100
15
Takeda Pharmaceutical Company Limited
2699
6
Teva Pharmaceuticals International GmbH
326
4
Teva Pharmaceuticals USA, Inc.
626
4
Novartis AG
10175
3
Epizyme, Inc.
360
3
Generation Bio Co.
151
3
Agency for Science, Technology and Research
3753
2
Ideaya Biosciences, Inc.
163
2
IVAX International GmbH
6
2
National University of Singapore
2601
2
GlaxoSmithKline Intellectual Property (No.3) Limited
7
2
AstraZeneca AB
2824
1
AstraZeneca UK Limited
522
1
Boehringer Ingelheim International GmbH
4485
1
Syngenta Crop Protection AG
6738
1
Abbott Laboratories
2236
1
Bayer Pharma AG
1009
1
Abbott GmbH & Co. KG
101
1
The Board of Trustees of Illinois State University
22
1
Other owners 22